Linoleic Acid-Menthyl Ester Reduces the Secretion of Apolipoprotein B100 in HepG2 Cells

被引：3

作者：

Inoue, Nao ^{[1
]}

Yamano, Naomi ^{[1
]}

Sakata, Kotaro ^{[1
]}

Arao, Keisuke ^{[2
]}

Kobayashi, Takashi ^{[3
]}

Naga, Toshihiro ^{[4
]}

Shimada, Yuji ^{[4
]}

Nagao, Koji ^{[1
]}

Yanagita, Teruyoshi ^{[1
]}

机构：

[1] Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan

[2] Nishikyushu Univ, Dept Hlth & Nutr Sci, Kanzaki 8428585, Japan

[3] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan

[4] Osaka Municipal Tech Res Inst, Biomat & Commod Chem Res Div, Osaka 5368553, Japan

来源：

JOURNAL OF OLEO SCIENCE | 2009年 / 58卷 / 04期

关键词：

linoleic acid-menthyl ester; apolipoprotein B100; apolipoprotein A-1; HepG2; cells; ASCORBYL PALMITATE; INHIBITION; LIPIDS;

D O I：

10.5650/jos.58.171

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

The effect of linoleic acid-menthyl ester (LAME) on lipid metabolism were assessed in HepG2 cells. It is well known that high level of apolipoprotein (apo) B100 in the serum is risk for atherosclerosis. Although linoleic acid (LA) treatment and LA plus L-mentol treatment increased apo B100 secretion, LAME treatment significantly decreased apo B100 secretion in HepG2 cells compared with control medium. The hypolipidemic effect of LAME was attributable to the suppression of triglyceride synthesis in HepG2 cells. It is also known that the risk of coronary heart disease is negatively related to the concentration of serum apo A-L In the present study, LAME treatment increased apo A-1 secretion as compared with LA treatment in HepG2 cells. These results suggest that mentyl-esterification of fatty acids may be beneficial in anti-atherogenic dietary therapy.

引用

页码：171 / 175

页数：5

共 50 条

[21] Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2)
Haghpassand, M
Wilder, D
Moberly, JB
JOURNAL OF LIPID RESEARCH, 1996, 37 (07) : 1468 - 1480
[22] The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells
Casaschi, A
Maiyoh, GK
Rubio, BK
Li, RW
Adeli, K
Theriault, AG
JOURNAL OF NUTRITION, 2004, 134 (06): : 1340 - 1346
[23] Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells
Sakata, N
Phillips, TE
Dixon, JL
JOURNAL OF LIPID RESEARCH, 2001, 42 (12) : 1947 - 1958
[24] 7-KETOCHOLESTEROL INCREASES HEPG2 CELLULAR CHOLESTERYL ESTER CONCENTRATION, CHOLESTERYL ESTER SECRETION, BUT NOT APOLIPOPROTEIN-B SECRETION
WARNER, GJ
ADDIS, PB
CARR, TP
HASSEL, CA
FASEB JOURNAL, 1994, 8 (04): : A453 - A453
[25] The soy phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion by HepG2 cells
Wilcox, LJ
de Dreu, LE
Borradaile, NM
Huff, MW
CIRCULATION, 1999, 100 (18) : 109 - 110
[26] Comparison of the Effect of trans Fatty Acid Isomers on Apolipoprotein A1 and B Secretion in HepG2 Cells
Nagao, Koji
Yoshinaga, Kazuaki
Nagai, Toshiharu
Mizobe, Hoyo
Yoshida, Akihiko
Beppu, Fumiaki
Gotoh, Naohiro
JOURNAL OF OLEO SCIENCE, 2017, 66 (10) : 1175 - 1181
[27] Endogenous cholesterol synthesis determines the rate of VLDL2 apolipoprotein B100 secretion and not VLDL1 apolipoprotein B100 secretion in humans
Prinsen, B
Romijn, JA
Bisschop, P
de Barse, M
Sauerwein, H
Rabelink, T
de Sain-van der Velden, M
CIRCULATION, 2002, 106 (19) : 253 - 253
[28] EVIDENCE FOR A LACK OF REGULATION OF THE ASSEMBLY AND SECRETION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEIN FROM HEPG2 CELLS BY CHOLESTERYL ESTER
WU, XJ
SAKATA, N
LUI, E
GINSBERG, HN
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (16) : 12375 - 12382
[29] Linoleic acid enhances the secretion of plasminogen activator inhibitor type 1 by HepG2 cells
Banfi, C
Rise, P
Mussoni, L
Galli, C
Tremoli, E
JOURNAL OF LIPID RESEARCH, 1997, 38 (05) : 860 - 869
[30] INTRACELLULAR CHOLESTEROL ESTER ACCUMULATION IN HEPG2 CELLS AND APO-B SECRETION
CIANFLONE, K
KOHENAVRAMOGLU, R
SNIDERMAN, AD
CIRCULATION, 1994, 90 (04) : 185 - 185

← 1 2 3 4 5 →